The Limb Salvage Center

Filter Your Results




Treating Complex Femoropopliteal Lesions

Takao Ohki, MD, PhD

September 2006—A case presentation showing how modern endovascular tools can facilitate optimal treatment.

Laser Treatment

Robert Gallino, MD

September 2006—Using the Spectranetics Turbo catheter to treat a calcified lesion and a thrombotic occlusion in the SFA

Embolic Protection in Femoropopliteal Artery Intervention

Hank J. Freeman, MD, and John H. Rundback, MD

October 2006—What devices are available and when is it necessary?

The Final Rule

Roseanne R. Wholey

October 2006—The 2007 hospital in-patient prospective payment system final rule.

An Interview With David H. Deaton, MD

November 2006—A prominent vascular surgeon shares his experiences with AAA devices, the PAD Coalition, and how surgery is a family business.

Establishing a Peripheral Vascular Center of Excellence

David E. Allie, MD; Chris J. Hebert, RT, R-CIS; and Craig M. Walker, MD

February 2005—It’s much more than just technology.

Therapeutic Angiogenesis

Toshio Matsuhashi, MD; Dara L. Kraitchman, VMD, PhD; and Lawrence V. Hofmann, MD

July 2005—Is peripheral arterial disease treatment evolving from stents to stem cells?

Subintimal Angioplasty for the Management of Chronic Total Occlusions

Larry Horesh, MD

October 2005—Subintimal angioplasty is an effective tool for the management of long-segment chronic total occlusions, particularly in higher Rutherford category patients.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.